CLIFTON LIFE SCIENCES

Clifton Life Sciences (CLS) is a leader in the emerging field of liquid biopsies. It focuses on the development of blood-based molecular diagnostic tests for personalized oncological medicine. The company's products and services are based on its proprietary technology involving the identification of molecular signatures for a variety of different cancers... Clifton Life Sciences provides a unique diagnostic mix of expertise in oncology, gastroenterology, bronchopulmonary, neuroendocrinology and biomathematics. It has a proven track record in the development of peripheral blood signatures for neuroendocrine and prostate cancers diagnosis and management. The company aim is to identify and develop peripheral blood markers that may serve as more accessible surrogates to detect other cancers including breast, colon, lung, ovarian, pancreas, melanoma and myeloma. Our goal is to develop in vitro diagnostics that are not only diagnostic but predictive of drug treatment efficacy and can..

Primary location: Branford United States